Please assess the completion status of the following clinical trial:

Trial Title: Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Planned computed tomography urogram (CTU)~* Statin naive, or not on statin treatment for at least 14 day~Exclusion Criteria:~* History of liver disease or elevated serum transaminases~* History of rhabdomyolysis or elevated creatinine kinase~* History of iodinated CM use within 14 days before randomization~* History of N-acetylcysteine, metformin or nonsteroidal anti-inflammatory drugs use within 48 hours of the procedure.~* History of hypersensitivity reaction to contrast media~* Pregnancy or lactation~* Acute renal failure~* End-stage renal disease requiring dialysis~* Cardiogenic shock or pulmonary edema~* Multiple myeloma

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Atorvastatin-Ascorbic acid (Type: ACTIVE_COMPARATOR): atorvastatin (80-mg loading dose given a mean 24 hours before procedure with another 40-mg dose approximately 2 hours before the procedure and for 3 days) plus ascorbic acid 500mg
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).